• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Primary hyperoxaluria: the adult nephrologist's point of view.原发性高草酸尿症:成人肾脏病专家的观点
Clin Kidney J. 2022 May 17;15(Suppl 1):i29-i32. doi: 10.1093/ckj/sfac068. eCollection 2022 May.
2
Primary hyperoxaluria: the pediatric nephrologist's point of view.原发性高草酸尿症:儿科肾脏病专家的观点。
Clin Kidney J. 2022 May 17;15(Suppl 1):i23-i28. doi: 10.1093/ckj/sfab231. eCollection 2022 May.
3
Recurrence of crystalline nephropathy after kidney transplantation in APRT deficiency and primary hyperoxaluria.腺嘌呤磷酸核糖转移酶缺乏症和原发性高草酸尿症患者肾移植后结晶性肾病的复发
Can J Kidney Health Dis. 2015 Sep 15;2:31. doi: 10.1186/s40697-015-0069-2. eCollection 2015.
4
Primary Hyperoxaluria Type 1 (PH1) Presenting With End-Stage Kidney Disease and Cutaneous Manifestations in Adulthood: A Case Report.成年期终末期肾病和皮肤表现的1型原发性高草酸尿症(PH1):病例报告
Can J Kidney Health Dis. 2021 Nov 22;8:20543581211058931. doi: 10.1177/20543581211058931. eCollection 2021.
5
Combined liver-kidney transplantation for primary hyperoxaluria type 1 in young children.小儿1型原发性高草酸尿症的肝肾联合移植
Nephrol Dial Transplant. 2001 Feb;16(2):348-54. doi: 10.1093/ndt/16.2.348.
6
Primary hyperoxaluria diagnosed after kidney transplant: A review of the literature and case report of aggressive renal replacement therapy and lumasiran to prevent allograft loss.肾移植后诊断出的原发性高草酸尿症:文献复习及强化肾脏替代治疗和 lumasiran 预防移植物丢失的病例报告。
Am J Transplant. 2021 Dec;21(12):4061-4067. doi: 10.1111/ajt.16762. Epub 2021 Jul 29.
7
Clinical features of genetically confirmed patients with primary hyperoxaluria identified by clinical indication versus familial screening.通过临床指征与家族筛查确定的原发性高草酸尿症基因确诊患者的临床特征。
Kidney Int. 2020 Apr;97(4):786-792. doi: 10.1016/j.kint.2019.11.023. Epub 2019 Dec 13.
8
Primary hyperoxaluria: a rare but important cause of nephrolithiasis.原发性高草酸尿症:肾结石的一种罕见但重要的病因。
Hong Kong Med J. 2002 Jun;8(3):202-6.
9
Primary hyperoxaluria in an adult presenting with end-stage renal failure together with hypercalcemia and hypothyroidism.一名成年患者出现终末期肾衰竭,同时伴有高钙血症和甲状腺功能减退,诊断为原发性高草酸尿症。
Hemodial Int. 2011 Oct;15(4):573-6. doi: 10.1111/j.1542-4758.2011.00573.x. Epub 2011 Jul 29.
10
Primary hyperoxaluria diagnosed after kidney transplantation: a case report and literature review.原发性高草酸尿症在肾移植后诊断:病例报告及文献复习。
BMC Nephrol. 2021 Nov 27;22(1):393. doi: 10.1186/s12882-021-02546-0.

引用本文的文献

1
Functional analysis of amino acid substitutions within human AGT1 in a cell-based platform to support the diagnosis of primary hyperoxaluria type 1.在基于细胞的平台中对人AGT1内氨基酸取代进行功能分析,以支持1型原发性高草酸尿症的诊断。
J Biol Chem. 2025 Jul 17;301(8):110494. doi: 10.1016/j.jbc.2025.110494.
2
Primary hyperoxaluria type 1 diagnosis in adult dialysis patients: prediction model assessment in a group of Italian patients.成年透析患者原发性1型高草酸尿症的诊断:一组意大利患者的预测模型评估
J Nephrol. 2025 Jun 4. doi: 10.1007/s40620-025-02243-3.
3
Opportunities in Primary and Enteric Hyperoxaluria at the Cross-Roads Between the Clinic and Laboratory.原发性和肠道高草酸尿症在临床与实验室之间交叉路口的机遇
Kidney Int Rep. 2024 Sep 1;9(11):3083-3096. doi: 10.1016/j.ekir.2024.08.031. eCollection 2024 Nov.
4
Mutation Characteristics of Primary Hyperoxaluria in the Chinese Population and Current International Diagnosis and Treatment Status.中国人群原发性高草酸尿症的突变特征及当前国际诊断与治疗现状
Kidney Dis (Basel). 2024 Jun 17;10(4):313-326. doi: 10.1159/000539516. eCollection 2024 Aug.

本文引用的文献

1
Safety, pharmacodynamics, and exposure-response modeling results from a first-in-human phase 1 study of nedosiran (PHYOX1) in primary hyperoxaluria.在原发性高草酸尿症的首次人体 1 期 PHYOX1(nedosiran)研究中,安全性、药效学和暴露-反应建模结果。
Kidney Int. 2022 Mar;101(3):626-634. doi: 10.1016/j.kint.2021.08.015. Epub 2021 Sep 2.
2
The Struggling Odyssey of Infantile Primary Hyperoxaluria.婴儿原发性高草酸尿症的艰难历程
Front Pediatr. 2021 Apr 20;9:615183. doi: 10.3389/fped.2021.615183. eCollection 2021.
3
A report from the European Hyperoxaluria Consortium (OxalEurope) Registry on a large cohort of patients with primary hyperoxaluria type 3.原发性高草酸尿症 3 型患者的大型队列的欧洲高草酸尿症联合会(OxalEurope)登记处报告。
Kidney Int. 2021 Sep;100(3):621-635. doi: 10.1016/j.kint.2021.03.031. Epub 2021 Apr 16.
4
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1.卢马昔兰,用于 1 型原发性高草酸尿症的 RNAi 疗法。
N Engl J Med. 2021 Apr 1;384(13):1216-1226. doi: 10.1056/NEJMoa2021712.
5
Clinical characterization of primary hyperoxaluria type 3 in comparison with types 1 and 2.原发性高草酸尿症 3 型与 1 型和 2 型的临床特征比较。
Nephrol Dial Transplant. 2022 Apr 25;37(5):869-875. doi: 10.1093/ndt/gfab027.
6
Structural and chemical heterogeneities of primary hyperoxaluria kidney stones from pediatric patients.原发性高草酸尿症肾结石患儿结石的结构和化学成分的异质性。
J Pediatr Urol. 2021 Apr;17(2):214.e1-214.e11. doi: 10.1016/j.jpurol.2020.11.023. Epub 2020 Nov 20.
7
Pathophysiology and Treatment of Enteric Hyperoxaluria.肠源性高草酸尿症的病理生理学和治疗。
Clin J Am Soc Nephrol. 2021 Mar 8;16(3):487-495. doi: 10.2215/CJN.08000520. Epub 2020 Sep 8.
8
Calcium oxalate crystal deposition in the kidney: identification, causes and consequences.肾脏草酸钙晶体沉积:鉴定、病因与后果。
Urolithiasis. 2020 Oct;48(5):377-384. doi: 10.1007/s00240-020-01202-w. Epub 2020 Jul 27.
9
Patients with primary hyperoxaluria type 2 have significant morbidity and require careful follow-up.2 型原发性高草酸尿症患者有显著的发病率,需要密切随访。
Kidney Int. 2019 Dec;96(6):1389-1399. doi: 10.1016/j.kint.2019.08.018. Epub 2019 Sep 3.
10
Primary hyperoxaluria diagnosed after kidney transplantation failure: lesson from 3 case reports and literature review.原发性高草酸尿症在肾移植失败后确诊:3 例病例报告及文献复习的经验教训。
BMC Nephrol. 2019 Jun 18;20(1):224. doi: 10.1186/s12882-019-1402-2.

原发性高草酸尿症:成人肾脏病专家的观点

Primary hyperoxaluria: the adult nephrologist's point of view.

作者信息

Moochhala Shabbir H, Worcester Elaine M

机构信息

Royal Free and University College Medical School, UCL Department of Renal Medicine, London, UK.

University of Chicago, Nephrology Section, South Maryland, Chicago, IL, USA.

出版信息

Clin Kidney J. 2022 May 17;15(Suppl 1):i29-i32. doi: 10.1093/ckj/sfac068. eCollection 2022 May.

DOI:10.1093/ckj/sfac068
PMID:35711295
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9194796/
Abstract

In adults, primary hyperoxaluria (PH) does not always present as obviously as in children, leading to delayed or even missed diagnosis. When diagnosed in adulthood, PH usually progresses at a slower rate and the focus is on the prevention of recurrent kidney stones as much as it is on the preservation of renal function. The most tragic presentation is when the diagnosis is made after primary non-function of a renal graft for treating previously unknown renal disease. Recurrent stones, nephrocalcinosis and features of systemic oxalosis can all be presenting features. For these reasons, consideration should be given to screening for this rare condition, using biochemical and/or genetic means, but being careful to exclude common differential diagnoses. Such efforts should be synchronized with diagnostic methods for other rare kidney diseases.

摘要

在成人中,原发性高草酸尿症(PH)并不总是像在儿童中那样表现得很明显,从而导致诊断延迟甚至漏诊。在成年期被诊断出时,PH通常进展较慢,重点是预防复发性肾结石以及保护肾功能。最悲惨的情况是在为治疗先前未知的肾脏疾病而进行的肾移植原发性无功能后才做出诊断。复发性结石、肾钙质沉着症和全身性草酸中毒的特征都可能是临床表现。出于这些原因,应考虑使用生化和/或基因手段对这种罕见疾病进行筛查,但要注意排除常见的鉴别诊断。这种努力应与其他罕见肾脏疾病的诊断方法同步进行。